Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
CONCLUSIONS: Using our methodology, we find most biologics cluster together with respect to short-term efficacy and tolerability, and we do not identify any single agent as 'best'. These data need to be interpreted in the context of longer-term efficacy, effectiveness data, safety, posology, and drug acquisition costs when making treatment decisions.
PMID: 32562551 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Mahil SK, Ezejimofor MC, Exton LS, Manounah L, Burden AD, Coates LC, de Brito M, McGuire A, Murphy R, Owen CM, Parslew R, Woolf RT, Yiu ZZN, Uthman OA, Mohd Mustapa MF, Smith CH Tags: Br J Dermatol Source Type: research
More News: Databases & Libraries | Dermatology | Enbrel | Humira | Methotrexate | Psoriasis | Remicade | Skin | Stelara | Study | UK Health